Related Experiment Videos
Rheumatoid arthritis as a risk factor for multiple myeloma: a case-control study
1Department of Oncology, University Hospital, Umeå, Sweden.
Summary
Rheumatoid arthritis increases multiple myeloma risk, while other diseases do not. Diagnostic X-rays and radiotherapy for benign conditions may also be risk factors for this blood cancer.
Area of Science:
- Epidemiology
- Oncology
- Rheumatology
Background:
- Multiple myeloma is a cancer of plasma cells.
- Understanding risk factors for multiple myeloma is crucial for prevention and early detection.
- Previous studies have suggested potential links between autoimmune diseases and cancer, but evidence requires further investigation.
Purpose of the Study:
- To investigate the association between rheumatoid arthritis, other diseases, and treatments with the risk of developing multiple myeloma.
- To identify specific risk factors contributing to multiple myeloma development.
Main Methods:
- A population-based case-control study was conducted in northern Sweden.
- 275 confirmed multiple myeloma cases were matched with an equal number of control subjects.
- Data on diseases, medications, diagnostic X-rays, and radiotherapy were collected via questionnaires.
Main Results:
- A confirmed association was found between rheumatic diseases, particularly rheumatoid arthritis, and an increased risk of multiple myeloma.
- No other diseases were associated with an increased myeloma risk; they were more common in controls.
- Fewer diagnostic X-rays and medications were used by myeloma cases compared to controls, though X-ray investigations showed some support as a potential risk factor.
- Radiotherapy for benign conditions was more frequent in cases, whereas radiotherapy for malignant diseases was more common in controls.
Conclusions:
- Rheumatoid arthritis is a significant risk factor for multiple myeloma.
- The findings suggest that diagnostic X-ray investigations and radiotherapy for benign conditions warrant further research as potential contributors to multiple myeloma risk.